Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

and Growth

- PMLiVE

Sanofi unveils $20bn US investment to boost R&D and manufacturing presence

The company is the latest major drugmaker to announce a significant investment in the country

Biogen Idec building

Biogen unveils plans for new global headquarters and R&D hub in US

The company is expecting to relocate its Cambridge-based employees to the new site in 2028

- PMLiVE

AstraZeneca announces $2.5bn investment in China to boost R&D capabilities

The funds will go towards a new global research and development centre in Beijing’s BioPark

- PMLiVE

ABPI highlights importance of NHS-industry partnerships in improving patient outcomes

Hospitals engaging in industry partnerships were found to be up to 2.5 times more likely to follow NICE guidelines

- PMLiVE

Ipsen announces launch of new UK headquarters in London life sciences community

The Paddington site will serve as one of the company’s three global hubs

- PMLiVE

AstraZeneca announces plans to invest £650m in UK to boost life sciences sector

The investment will also help to enhance public health protection and pandemic preparedness in the UK

- PMLiVE

ABPI sets out UK life sciences industry’s priorities for government’s budget

The ABPI highlights four key areas where the budget could boost UK life sciences

- PMLiVE

ABPI publishes new prescribing support guide for healthcare professionals

The report will help pharmaceutical companies support high-quality healthcare

Matt Hunt

How we’re making AI a part of life at 11 London

This article talks about how AI is being used more in advertising, showing how it can change the way things are done from planning out strategies to coming up with...

11 London

- PMLiVE

ABPI publishes manifesto for government to accelerate UK life sciences industry

The trade association has called on political parties to commit to three broad goals and requirements

- PMLiVE

New economic data reveals risk of disincentivising UK life sciences growth

UK rebate rates are significantly higher than in other countries with similar mechanisms

- PMLiVE

NHS and pharmaceutical industry partnerships to change millions of lives

The report highlights how UK ICSs and the pharmaceutical industry can work together

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links